Showing 2681-2690 of 10545 results for "".
It's Complicated
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/its-complicated/20627/One surgeon discusses why you should embrace complications.Focusing on Patient Education in Atopic Dermatitis
https://practicaldermatology.com/topics/practice-management/focusing-on-patient-education-in-atopic-dermatitis/20661/Patients of all ages have atopic dermatitis, and they seek education and support from their dermatologists.Core Marketing Philosophies and Your Practice
https://practicaldermatology.com/topics/practice-management/core-marketing-philosophies-and-your-practice/21032/The most successful practices treat formulas and strategies as loose parameters rather than hard-set rules to adhere to.Demodex: Exploring Its Role in Rosacea
https://practicaldermatology.com/topics/practice-management/demodex-exploring-its-role-in-rosacea/21100/Although the relationship is not fully understood, targeting the mites often improves skin symptoms of rosacea.The Future of Interleukin-based Therapy
https://practicaldermatology.com/topics/practice-management/the-future-of-interleukin-based-therapy/21133/IL inhibitors offer the promise of increased efficacy. Here is a snapshot view of current and investigational agents.How To Overcome “LCD” Planning in a Group Practice
https://practicaldermatology.com/topics/practice-management/how-to-overcome-lcd-planning-in-a-group-practice/21182/Concepts to be implemented to help you avoid LCD planning and address significant financial threats.DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's latesThe Google+ Hangout: A Marketing Tool For Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/the-google-hangout-a-marketing-tool-for-your-dermatology-practice/21423/Dermatology marketers can employ this tool effectively to promote their practices or simply use it as a powerful and free communication tool.PR Is the Next Big Thing for Online Dermatology Marketing
https://practicaldermatology.com/topics/practice-management/pr-is-the-next-big-thing-for-online-dermatology-marketing/22954/Dermatology marketers should evaluate current SEO to make room for public relations strategies.Filler Pearls: Refining the Art of Injection
https://practicaldermatology.com/topics/general-topics/filler-pearls-refining-the-art-of-injection/21683/Pain control is essential to treatment success with dermal fillers. Here's an update on pain management and other tactics to ensure patient comfort and optimize outcomes.